🔎 Trials Near Me

Hjem › Hypertrofisk kardiomyopati › Massachusetts

Hypertrofisk kardiomyopati kliniske forsøg i Massachusetts

6 studier for Hypertrofisk kardiomyopati søger deltagere på steder i Massachusetts.

Byer i Massachusetts

Officiel studietekst (engelsk)

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  • Harvard (Massachusetts General Hospital), Boston
  • Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05489705

Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis

  • Tufts Medical Center, Boston
  • Boston Medical Center, Boston
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 50 og opefter · Alle køn · Opdateret 4. jun. 2026 · NCT06034405

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

  • Imbria Investigational Site, Boston
  • Imbria Investigational Site, Burlington
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. maj 2026 · NCT07023614

A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

  • Boston Children's Hospital, Boston
RekruttererFase 2
Alder 8 og opefter · Mænd · Opdateret 4. maj 2026 · NCT06092034

HCMR Re-Imaging Study

  • Brigham & Women's Hospital, Boston
  • Tufts Medical Center, Medford
RekruttererObservationsstudie
Alder 18 til 65 · Alle køn · Opdateret 18. mar. 2026 · NCT07054073

Real-world Patient Reported Outcomes Among Patients Treated With Camzyos

  • Analysis Group Inc., Boston
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 7. nov. 2024 · NCT06551129

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.